Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study

被引：0
|
作者：
Pearce, Ian [1 ]
Parikh, Soumil [2 ]
Macfadden, Wayne [2 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[2] Novartis Pharma AG, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2566
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Real-world outcomes of ranibizumab treatment in patients with retinal vein occlusion: the LUMINOUS™ study
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [2] Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study
    Pearce, Ian
    Clemens, Andreas
    Brent, Michael H.
    Lu, Lin
    Gallego-Pinazo, Roberto
    Minnelle, Angelo Maria
    Creuzot-Garcher, Catherine
    Spital, Georg
    Sakamoto, Taiji
    Dunger-Baldauf, Cornelia
    McAllister, Ian L.
    PLOS ONE, 2020, 15 (06):
  • [3] Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study
    Lotery, Andrew
    Clemens, Andreas
    Tuli, Raman
    Xu, Xun
    Shimura, Masahiko
    Nardi, Marco
    Ziemssen, Focke
    Dunger-Baldauf, Cornelia
    Tadayoni, Ramin
    EYE, 2022, 36 (08) : 1656 - 1661
  • [4] Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study
    Andrew Lotery
    Andreas Clemens
    Raman Tuli
    Xun Xu
    Masahiko Shimura
    Marco Nardi
    Focke Ziemssen
    Cornelia Dunger-Baldauf
    Ramin Tadayoni
    Eye, 2022, 36 : 1656 - 1661
  • [5] One-year outcomes of ranibizumab treatment in a cohort of patients with retinal vein occlusion: an interim analysis from the real-world LUMINOUS study
    Pearce, Ian A.
    Das Gupta, Ayan
    Lacey, Sue
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [6] Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
    Callizo, Josep
    Ziemssen, Focke
    Bertelmann, Thomas
    Feltgen, Nicolas
    Voegeler, Jessica
    Koch, Mirja
    Eter, Nicole
    Liakopoulos, Sandra
    Schmitz-Valckenberg, Steffen
    Spital, Georg
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 2167 - 2179
  • [7] ONE YEAR REAL-WORLD OUTCOMES OF RANIBIZUMAB IN NAMD: INTERIM RESULTS FROM THE GLOBAL LUMINOUS STUDY
    Mitchell, Paul
    Gilhotra, Jagjit Singh
    Vote, Brendan
    Walsh, Meagan
    Woodcock, Chad
    Kurstjens, Nicol
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 12 - 12
  • [8] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Vasileios E. Konidaris
    Konstantinos T. Tsaousis
    Rossella Anzidei
    Guillermo de la Mata
    Alexander J. Brent
    Ophthalmology and Therapy, 2018, 7 : 387 - 395
  • [9] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Konidaris, Vasileios E.
    Tsaousis, Konstantinos T.
    Anzidei, Rossella
    de la Mata, Guillermo
    Brent, Alexander J.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 387 - 395
  • [10] Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal
    Vaz-Pereira, Sara
    Marques, Ines P.
    Matias, Joao
    Mira, Filipe
    Ribeiro, Ligia
    Flores, Rita
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (06) : 756 - 761
12345